{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:23:19Z","timestamp":1770978199585,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ajp.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:30:41Z","timestamp":1336091441000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Agonist treatment in opioid use: Advances and controversy"],"prefix":"10.1016","volume":"5","author":[{"given":"Biju","family":"Viswanath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhat","family":"Chand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Benegal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratima","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2012.01.004_bib0005","first-page":"160","article-title":"Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts","volume":"45","author":"Ali","year":"1999","journal-title":"Sucht"},{"key":"10.1016\/j.ajp.2012.01.004_bib0010","first-page":"CD004147","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence (Cochrane review)","volume":"4","author":"Amato","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ajp.2012.01.004_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"J. Subst. Abuse Treat."},{"issue":"82","key":"10.1016\/j.ajp.2012.01.004_bib0020","first-page":"64","article-title":"Buprenorphine replacement therapy a confirmed benefit","volume":"15","author":"Anonymous","year":"2006","journal-title":"Prescrire Int."},{"key":"10.1016\/j.ajp.2012.01.004_bib0025","unstructured":"Available on website National AIDS Control Organization. http:\/\/www.nacoonline.org\/upload\/Publication\/NGOs%20and%20targetted%20Intervations\/Standard%20Operating%20Procedures-Buprenorphine_NACO.pdf last visited on 19.12.2011."},{"key":"10.1016\/j.ajp.2012.01.004_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ajp.2012.01.004_bib0035","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1046\/j.1360-0443.2001.961014559.x","article-title":"Mortality among problem drug users in Rome: an 18-year follow-up study, 1980\u201397","volume":"96","author":"Bargagli","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1360-0443.2005.00937.x","article-title":"Matching of treatment-resistant heroin dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials","volume":"100","author":"Blanken","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2146\/ajhp060403","article-title":"Buprenorphine for the treatment of opioid dependence","volume":"64","author":"Boothby","year":"2007","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.ajp.2012.01.004_bib0050","series-title":"Goodman and Gilman's Manual of Pharmacology and Therapeutics","author":"Brunton","year":"2008"},{"key":"10.1016\/j.ajp.2012.01.004_bib0055","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5694\/j.1326-5377.1999.tb127675.x","article-title":"Mortality associated with New South Wales methadone programs in 1994: lives lost and saved","volume":"170","author":"Caplehorn","year":"1999","journal-title":"Med. J. Australia"},{"issue":"1","key":"10.1016\/j.ajp.2012.01.004_bib0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1360-0443.1993.tb02769.x","article-title":"Methadone dose and heroin use during maintenance treatment","volume":"88","author":"Caplehorn","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0065","series-title":"Medical Coprescription of Heroin: Two Randomised Controlled Trials","author":"Central Committee on the Treatment of Heroin Addicts (CCBH)","year":"2002"},{"key":"10.1016\/j.ajp.2012.01.004_bib0070","article-title":"Short-term outcome of take-home prescriptions for opioid dependence: a clinic based study","author":"Chand","year":"2011","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.ajp.2012.01.004_bib0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial","volume":"63","author":"Comer","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2012.01.004_bib0080","series-title":"Substance Use Disorders","first-page":"79","article-title":"Long term treatment of opioid dependence syndrome","author":"Dhawan","year":"2005"},{"key":"10.1016\/j.ajp.2012.01.004_bib0085","first-page":"1573","article-title":"Managing opioid addiction with buprenorphine","volume":"73","author":"Donaher","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ajp.2012.01.004_bib0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00213-002-1027-0","article-title":"High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans","volume":"161","author":"Donny","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ajp.2012.01.004_bib0095","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1360-0443.2005.01232.x","article-title":"Methadone doses of 100mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers","volume":"100","author":"Donny","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0100","unstructured":"Duraisamy, K., Nath, U., Subodh, B.N., Manjunath, N., Chand, P., Benegal, V., Murthy, P., 2010. Buprenorphine maintenance treatment: a study from south India. Poster Presented at the 62nd Annual National Conference of the Indian Psychiatric Society, Jaipur."},{"key":"10.1016\/j.ajp.2012.01.004_bib0105","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1360-0443.2005.001128.x","article-title":"Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy","volume":"100","author":"Eder","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0110","first-page":"CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","volume":"3","author":"Faggiano","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ajp.2012.01.004_bib0115","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bmj.316.7132.639","article-title":"The Swiss heroin trials: testing alternative approaches","volume":"316","author":"Farrell","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2012.01.004_bib0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-8716(01)00171-5","article-title":"Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis","volume":"65","author":"Farre","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ajp.2012.01.004_bib0125","first-page":"CD003410","article-title":"Heroin maintenance for chronic heroin dependents (Cochrane review)","volume":"2","author":"Ferri","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.ajp.2012.01.004_bib0130","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1360-0443.2006.01569.x","article-title":"A prospective cohort study on orally administered heroin substitution for severely addicted opioid users","volume":"101","author":"Frick","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0135","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ajp.2012.01.004_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0740-5472(03)00031-X","article-title":"Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables","volume":"25","author":"Gerra","year":"2003","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.ajp.2012.01.004_bib0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10826080500391845","article-title":"Opioid addicts at admission vs slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants","volume":"41","author":"Giacomuzzi","year":"2006","journal-title":"Subst. Use Misuse"},{"issue":"6","key":"10.1016\/j.ajp.2012.01.004_bib0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.yco.0000245759.13997.9d","article-title":"Innovations in agonist maintenance treatment of opioid-dependent patients","volume":"19","author":"Haasen","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2012.01.004_bib0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","article-title":"A 33-year follow-up of narcotics addicts","volume":"58","author":"Hser","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2012.01.004_bib0160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1360-0443.2006.01369.x","article-title":"Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review","volume":"101","author":"Johansson","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0165","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.ajp.2012.01.004_bib0170","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ajp.2012.01.004_bib0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1176\/ajp.2007.164.5.797","article-title":"A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial","volume":"164","author":"Kakko","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2012.01.004_bib0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugalcdep.2005.05.002","article-title":"Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver","volume":"80","author":"Kerr","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ajp.2012.01.004_bib0185","first-page":"1241","article-title":"A systematic review on the efficacy of oral naltrexone treatment in opioid dependence","volume":"92","author":"Kirchmayer","year":"1997","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.ajp.2012.01.004_bib0190","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1360-0443.1998.93811614.x","article-title":"Maintenance treatment of opiate addicts in Germany with medications containing codeine \u2013 results of a follow up study","volume":"93","author":"Krausz","year":"1998","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.ajp.2012.01.004_bib0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000085550","article-title":"Use of slow-release oral morphine for the treatment of opioid dependence","volume":"11","author":"Kraigher","year":"2005","journal-title":"Eur. Addict. Res."},{"issue":"4","key":"10.1016\/j.ajp.2012.01.004_bib0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jsat.2006.05.005","article-title":"Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia","volume":"31","author":"Krupitsky","year":"2006","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.ajp.2012.01.004_bib0205","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1196\/annals.1316.055","article-title":"Drug problem in southeast and southwest Asia","volume":"1025","author":"Kulsudjarit","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ajp.2012.01.004_bib0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-7517-6-4","article-title":"Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India: what has been established needs to be continued and expanded","volume":"6","author":"Kumar","year":"2009","journal-title":"Harm Reduct. J."},{"issue":"1","key":"10.1016\/j.ajp.2012.01.004_bib0215","first-page":"62","article-title":"Buprenorphine dependence\u2014analysis of seven cases","volume":"33","author":"Lal","year":"1991","journal-title":"Indian J. Psychiatry"},{"issue":"10","key":"10.1016\/j.ajp.2012.01.004_bib0220","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1360-0443.2007.01944.x","article-title":"Evaluation of a transdermal buprenorphine formulation in opioid detoxification","volume":"102","author":"Lanier","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0405","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1465-3362.2011.00304.x","article-title":"The availability, diversion and injection of pharmaceutical opioids in South Asia","volume":"30","author":"Larance","year":"2011","journal-title":"Drug and Alcohol Review"},{"issue":"5335","key":"10.1016\/j.ajp.2012.01.004_bib0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.278.5335.45","article-title":"Addiction is a brain disease, and it matters","volume":"278","author":"Leshner","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ajp.2012.01.004_bib0235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(03)00059-0","article-title":"Clinical efficacy of buprenorphine: comparisons to methadone and placebo","volume":"70","author":"Ling","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ajp.2012.01.004_bib0245","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2012.01.004_bib0250","series-title":"The Cochrane Library, Issue 3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane review)","author":"Mattick","year":"2004"},{"key":"10.1016\/j.ajp.2012.01.004_bib0255","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1001\/jama.1993.03500150065028","article-title":"The effects of psychosocial services in substance abuse treatment","volume":"269","author":"McLellan","year":"1993","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ajp.2012.01.004_bib0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1360-0443.2002.00127.x","article-title":"Have we evaluated addiction treatment correctly? Implications from a chronic care perspective","volume":"97","author":"McLellan","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0265","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","article-title":"Slow-release morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence","volume":"99","author":"Mitchell","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0270","series-title":"The Cochrane Library, Issue 1","article-title":"Oral naltrexone maintenance treatment for opioid dependence (Cochrane review)","author":"Minozzi","year":"2006"},{"key":"10.1016\/j.ajp.2012.01.004_bib0275","series-title":"Substance Use disorders","first-page":"16","article-title":"Epidemiology of substance use","author":"Pal","year":"2005"},{"key":"10.1016\/j.ajp.2012.01.004_bib0280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.317.7150.13","article-title":"Randomised trial of heroin maintenance for addicts who fail in conventional drug treatments","volume":"317","author":"Perneger","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ajp.2012.01.004_bib0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","article-title":"Double-blind randomized trial of buprenorphine and methadone in opiate dependence","volume":"62","author":"Petitjean","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ajp.2012.01.004_bib0290","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.57.4.395","article-title":"Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance","volume":"57","author":"Preston","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2012.01.004_bib0295","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/pds.975","article-title":"Post-marketing surveillance of buprenorphine","volume":"13","author":"Ray","year":"2004","journal-title":"Pharmacoepidemiol. Drug Safe."},{"key":"10.1016\/j.ajp.2012.01.004_bib0300","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(01)06529-1","article-title":"Feasibility, safety, and efficacy of injectable heroin description for refractory opioid addicts: a follow-up study","volume":"538","author":"Rehm","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2012.01.004_bib0305","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1440-1614.2002.01012.x","article-title":"Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose","volume":"36","author":"Ritter","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2012.01.004_bib0310","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euroneuro.2005.11.001","article-title":"A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence","volume":"16","author":"Roozen","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.ajp.2012.01.004_bib0315","first-page":"154","article-title":"Buprenorphine abuse in India: an update","volume":"41","author":"Sharma","year":"1999","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ajp.2012.01.004_bib0320","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1360-0443.2004.00834.x","article-title":"Evaluation of an injection depot formulation of buprenorphine: placebo comparison","volume":"99","author":"Sigmon","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.ajp.2012.01.004_bib0325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0447.1992.tb03224.x","article-title":"Cases of buprenorphine abuse in India","volume":"86","author":"Singh","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2012.01.004_bib0330","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1016\/j.drugalcdep.2003.08.006","article-title":"Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification","volume":"73","author":"Sobel","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ajp.2012.01.004_bib0335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130000637","article-title":"Effects of buprenorphine\/naloxone in opioid-dependent humans","volume":"154","author":"Stoller","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ajp.2012.01.004_bib0340","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.281.11.1000","article-title":"Moderate- versus high-dose methadone in the treatment of opioid dependence: a randomized trial","volume":"281","author":"Strain","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajp.2012.01.004_bib0345","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/10550490500528464","article-title":"Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial","volume":"15","author":"Sullivan","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.ajp.2012.01.004_bib0350","series-title":"World Drug Report 2005","author":"United Nations Office on Drugs Crime (UNODC)","year":"2011"},{"key":"10.1016\/j.ajp.2012.01.004_bib0355","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/002204269902900309","article-title":"Medical co-prescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands: a randomized clinical trial","volume":"29","author":"van den Brink","year":"1999","journal-title":"J. Drug Issues"},{"issue":"7410","key":"10.1016\/j.ajp.2012.01.004_bib0360","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","article-title":"Medical prescription of heroin to chronic, treatment-resistant heroin dependent patients: two randomized controlled trials","volume":"327","author":"van den Brink","year":"2003","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ajp.2012.01.004_bib0365","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.euroneuro.2003.08.008","article-title":"Pharmacological treatments for heroin and cocaine addiction","volume":"13","author":"van den Brink","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.ajp.2012.01.004_bib0370","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/070674370605101003","article-title":"Evidenced-based treatment of opioid dependent patients","volume":"51","author":"Van den Brink","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.ajp.2012.01.004_bib0375","first-page":"397","article-title":"Buprenorphine deviated from normal use: the buprenorphine injection","volume":"28","author":"Vareseon","year":"2002","journal-title":"Encephale"},{"issue":"2","key":"10.1016\/j.ajp.2012.01.004_bib0380","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000090423","article-title":"Safety and efficacy of oral slow release morphine for maintenance treatment in heroin addicts: a 6-month open noncomparative study","volume":"12","author":"Vasilev","year":"2006","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.ajp.2012.01.004_bib0385","series-title":"WHO Model List of Essential Medicines","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.ajp.2012.01.004_bib0390","series-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"World Health Organization","year":"2009"},{"issue":"7164","key":"10.1016\/j.ajp.2012.01.004_bib0395","first-page":"1011","article-title":"The Swiss heroin trials. Further studies of heroin treatment are needed","volume":"317","author":"Wodak","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2012.01.004_bib0400","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr. Drug Abuse Rev."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201812000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201812000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:21:46Z","timestamp":1761754906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201812000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1876201812000056"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2012.01.004","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agonist treatment in opioid use: Advances and controversy","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2012.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}